Neurocrine Biosciences (NasdaqGS:NBIX) Q4 2025 Earnings call February 11, 2026 04:30 PM ET Company ParticipantsCorinne Johnson - Managing DirectorDanielle Brill - Managing DirectorEric Benevich - Chief Commercial OfficerKyle Gano - CEOLuke Lapointe - Director of Global Healthcare GroupMatt Abernethy - CFOMohit Bansal - Managing DirectorPaul Matteis - Managing Director and Head of Therapeutics ResearchPhil Nadeau - Managing Director and Head of Healthcare Equity ResearchSanjay Keswani - Chief Medical Officer ...